Zimmer Biomet Holdings, Inc. (ZBH) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Medical - Devices
Zimmer Biomet Holdings, Inc. (ZBH) Profile & Business Summary
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Key Information
| Ticker | ZBH |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.zimmerbiomet.com |
Market Trend Overview for ZBH
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-07-13 (ET)
As of 2026-07-13, ZBH is starting to move higher. Over the longer term, the trend remains bullish.
ZBH last closed at 94.08. The price is about 2.6 ATR above its recent average price (87.86), and the market is currently in an early upward move. Price at 94.08 is holding above minor support near 90.31. If price continues higher, it may face minor resistance around 95.31. View Support & Resistance from Options
The broader uptrend is still intact, but price has moved far from its recent average, increasing the risk of a pullback.
Trend score: 80 out of 100. Overall alignment is strong. The market is currently in an early-stage uptrend. Trend signals are well aligned across timeframes, suggesting a stable and consistent trend.
Price is stretched well above its recent average (about 2.6 ATR). Upside extension is elevated, and chasing strength here carries a higher pullback risk.
A key downside risk boundary is near 83.50. If price falls below this area, the current structure would likely weaken further.
A systematic trend-activation signal was most recently triggered on 2026-07-13, reflecting a technical shift toward positive directional alignment.
[2026-06-12] Price moved quickly and looked strong, but participation was limited.
Recent price action shows orderly upward progression with no major deterioration in bar-level efficiency. Structural conditions remain broadly constructive.
Closing activity showed limited conviction and did not suggest strong overnight positioning.
The model sees a credible bullish edge, with 65.6% upside probability, strong signal alignment, and reward/risk that remains meaningfully favorable.
Up probability is 65.6%, with predictability at 60% and signal agreement at 93%. Reversal risk is 15%, while reward/risk stands at 0.34. That suggests the directional case is supported by broad confirmation and still retains usable quality. At the same time, recent price behavior has shown failed reversal memory.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is trading 5.4% above the recent estimated cost basis of 89.25, which keeps the recent cost structure in a clearly stronger position. Price is above the main cost band (88.52 to 92.73), and about 95% of recent positioning is already in profit. That supports trend strength, but it also raises the chance of profit-taking if momentum cools. The next lower support area sits around 93.16 to 93.38. It looks more like a first buffer than a major floor. The main cost band is fairly wide relative to recent ATR, so this structure may behave less cleanly than a tighter setup. From a trading point of view, the trend still has support. The main question is whether deeper pullbacks can still hold the next lower 93.16 to 93.38 support zone.